Clinical Trial Perspective part of Data fraud in clinical trials

2015 Highly publicized cases of fabrication or falsification of data in clinical trials have occurred in recent years and it is likely that there are additional undetected or unreported cases. We review the available evidence on the incidence of data fraud in clinical trials, describe several prominent cases, present information on motivation and contributing factors and discuss cost-effective ways of early detection of data fraud as part of routine central statistical monitoring of data quality. Adoption of these clinical trial monitoring procedures can identify potential data fraud not detected by conventional on-site monitoring and can improve overall data quality.

[1]  M. Buyse,et al.  Fraud in Clinical Trials , 2014 .

[2]  C Legrand,et al.  Linear mixed‐effects models for central statistical monitoring of multicenter clinical trials , 2014, Statistics in medicine.

[3]  Taghrid Obied,et al.  Oversight of clinical investigations- A risk based approach to monitoring , 2014 .

[4]  S. Evans,et al.  Central and statistical data monitoring in the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2) trial , 2014, Clinical trials.

[5]  Gary Gensler,et al.  Central site monitoring: Results from a test of accuracy in identifying trials and sites failing Food and Drug Administration inspection , 2014, Clinical trials.

[6]  A. Kimball,et al.  Research integrity in the modern era: current gaps in our knowledge and thinking , 2014 .

[7]  Allan Hackshaw,et al.  Application of methods for central statistical monitoring in clinical trials , 2013, Clinical trials.

[8]  M. Landray,et al.  Randomized clinical trials--removing unnecessary obstacles. , 2013, The New England journal of medicine.

[9]  Arturo Casadevall,et al.  Why Has the Number of Scientific Retractions Increased? , 2013, PloS one.

[10]  John F. Sargent,et al.  The U.S. Science and Engineering Workforce: Recent, Current, and Projected Employment, Wages, and Unemployment , 2013 .

[11]  S. Yusuf,et al.  Central statistical monitoring: Detecting fraud in clinical trials , 2013, Clinical Trials.

[12]  Canary Wharf,et al.  Reflection paper on risk based quality management in clinical trials , 2013 .

[13]  Catrin Tudur Smith,et al.  The Value of Source Data Verification in a Cancer Clinical Trial , 2012, PloS one.

[14]  W. Stroebe,et al.  Scientific Misconduct and the Myth of Self-Correction in Science , 2012, Perspectives on psychological science : a journal of the Association for Psychological Science.

[15]  Donald R. Miller.  Retraction of articles written by Dr. Yoshitaka Fujii , 2012, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[16]  A. Casadevall,et al.  Misconduct accounts for the majority of retracted scientific publications , 2012, Proceedings of the National Academy of Sciences.

[17]  Tomasz Burzykowski,et al.  A statistical approach to central monitoring of data quality in clinical trials , 2012, Clinical trials.

[18]  J. Carlisle,et al.  The analysis of 168 randomised controlled trials to test data integrity , 2012, Anaesthesia.

[19]  G. Loewenstein,et al.  Measuring the Prevalence of Questionable Research Practices With Incentives for Truth Telling , 2012, Psychological science.

[20]  Sheena McCormack,et al.  The potential for central monitoring techniques to replace on-site monitoring: findings from an international multi-centre clinical trial , 2012, Clinical trials.

[21]  D. Galton.  Did Mendel falsify his data? , 2012, QJM : monthly journal of the Association of Physicians.

[22]  M. Avery,et al.  FDA Enforcement of Criminal Liability for Clinical Investigator Fraud , 2012 .

[23]  Valdés-Márquez Elsa,et al.  A key risk indicator approach to central statistical monitoring in multicentre clinical trials: method development in the context of an ongoing large-scale randomized trial , 2011, Trials.

[24]  James D Neaton,et al.  Monitoring the quality of conduct of clinical trials: a survey of current practices , 2011, Clinical trials.

[25]  Lawrence Souder,et al.  A Rhetorical Analysis of Apologies for Scientific Misconduct: Do They Really Mean It? , 2010, Sci. Eng. Ethics.

[26]  M. Broome,et al.  Research Coordinators' Experiences With Scientific Misconduct and Research Integrity , 2010, Nursing research.

[27]  Melissa S. Anderson,et al.  Institutions' Expectations for Researchers' Self-Funding, Federal Grant Holding, and Private Industry Involvement: Manifold Drivers of Self-Interest and Researcher Behavior , 2009, Academic medicine : journal of the Association of American Medical Colleges.

[28]  D. Fanelli.  How Many Scientists Fabricate and Falsify Research? A Systematic Review and Meta-Analysis of Survey Data , 2009, PloS one.

[29]  Benjamin K. Sovacool,et al.  Exploring Scientific Misconduct: Isolated Individuals, Impure Institutions, or an Inevitable Idiom of Modern Science? , 2008 .

[30]  Douglas G Altman,et al.  Ensuring trial validity by data quality assurance and diversification of monitoring methods , 2008, Clinical trials.

[31]  Peter Sandercock,et al.  Sensible approaches for reducing clinical trial costs , 2008, Clinical trials.

[32]  Mark S. Davis,et al.  Causal Factors Implicated in Research Misconduct: Evidence from ORI Case Files , 2007, Sci. Eng. Ethics.

[33]  M. LaFollette.  The Great Betrayal: Fraud in Science , 2007 .

[34]  R. Horton.  Retraction—Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study , 2006, The Lancet.

[35]  R. Horton.  Expression of concern: non-steroidal anti-inflammatory drugs and the risk of oral cancer , 2006, The Lancet.

[36]  J. Sudbø,et al.  RETRACTED: Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study , 2005, The Lancet.

[37]  D. Resnik.  The ethics of science: An introduction , 2005 .

[38]  Stephen Evans,et al.  Are these data real? Statistical methods for the detection of data fabrication in clinical trials , 2005, BMJ : British Medical Journal.

[39]  David Moher,et al.  The Good Clinical Practice guideline: a bronze standard for clinical research , 2005, The Lancet.

[40]  K. Pimple,et al.  Research Misconduct and Crime Lessons from Criminal Science on Preventing Misconduct and Promoting Integrity , 2005, Accountability in research.

[41]  Melissa S. Anderson,et al.  Scientists behaving badly , 2005, Nature.

[42]  Michael W. Kalichman,et al.  The Great Betrayal: Fraud in Science , 2005 .

[43]  S. Reynolds.  ORI findings of scientific misconduct in clinical trials and publicly funded research, 1992–2002 , 2004, Clinical trials.

[44]  Nicholas H. Steneck,et al.  Assessing the Integrity of Publicly Funded Research , 2004 .

[45]  M. Loui,et al.  How a Cancer Trial Ended in Betrayal , 2002 .

[46]  M. Farthing.  Research misconduct: diagnosis, treatment and prevention , 2000, The British journal of surgery.

[47]  P. Kranke,et al.  Reported data on granisetron and postoperative nausea and vomiting by Fujii et al. Are incredibly nice! , 2000, Anesthesia and analgesia.

[48]  Richard Horton.  After Bezwoda , 2000, The Lancet.

[49]  R. Theriault,et al.  High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study , 2000, The Lancet.

[50]  J Ranstam,et al.  Fraud in medical research: an international survey of biostatisticians. ISCB Subcommittee on Fraud. , 2000, Controlled clinical trials.

[51]  P. Lachenbruch,et al.  The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. , 1999, Statistics in medicine.

[52]  G. Kolata,et al.  A doctor's drug studies turn into fraud. , 1999, The New York times on the Web.

[53]  D L DeMets,et al.  Distinctions between fraud, bias, errors, misunderstanding, and incompetence. , 1997, Controlled clinical trials.

[54]  Stephen L. George,et al.  Perspectives on Scientific Misconduct and Fraud in Clinical Trials , 1997 .

[55]  D. Sackett,et al.  The trials of Dr. Bernard Fisher: a European perspective on an American episode. , 1997, Controlled clinical trials.

[56]  Hans-Christoph Diener,et al.  European Stroke Prevention Study 2. Efficacy and safety data. , 1997, Journal of the neurological sciences.

[57]  F. Wells.  Fraud and misconduct in medical research. , 1997, British journal of clinical pharmacology.

[58]  T. Hill.  A Statistical Derivation of the Significant-Digit Law , 1995 .

[59]  G. Jacobsen,et al.  Medical Investigators' Views about Ethics and Fraud in Medical Research , 1995, Journal of the Royal College of Physicians of London.

[60]  E. Howard.  Science Misconduct and Due Process: A Case of Process Due , 1994 .

[61]  G. Richer.  Fraud in breast-cancer trials. , 1994, The New England journal of medicine.

[62]  David P. Hamilton.  In the trenches, doubts about scientific integrity. , 1992, Science.

[63]  IOM report of a study on the responsible conduct of research in the health sciences. , 1989, Clinical research.

[64]  Donald Evans,et al.  Betrayers of the Truth: Fraud and Deceit in Science , 1986 .

[65]  R. Newton.  The crime of Claudius Ptolemy , 1977 .

[66]  Rory A. Fisher,et al.  Has Mendel's work been rediscovered? , 1936 .